<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/623C14B8-7424-410A-BA88-2C2D7BBFC2D5"><gtr:id>623C14B8-7424-410A-BA88-2C2D7BBFC2D5</gtr:id><gtr:name>Ozics</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Eastman Dental Institute</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/623C14B8-7424-410A-BA88-2C2D7BBFC2D5"><gtr:id>623C14B8-7424-410A-BA88-2C2D7BBFC2D5</gtr:id><gtr:name>Ozics</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/38F63FEB-2D90-4817-B9D3-ADE05F0B9A25"><gtr:id>38F63FEB-2D90-4817-B9D3-ADE05F0B9A25</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>Graeme</gtr:otherNames><gtr:surname>Buxton</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/12527535-2F89-457C-B033-20AEA6FAD5D0"><gtr:id>12527535-2F89-457C-B033-20AEA6FAD5D0</gtr:id><gtr:firstName>Anne</gtr:firstName><gtr:otherNames>Margaret</gtr:otherNames><gtr:surname>Young</gtr:surname><gtr:orcidId>0000-0001-8485-2056</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2C480718-5868-49CC-85D8-109463BD1079"><gtr:id>2C480718-5868-49CC-85D8-109463BD1079</gtr:id><gtr:firstName>Nikolaos</gtr:firstName><gtr:surname>Mardas</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0701855"><gtr:id>39BE4818-8ADE-4E0E-B9E4-F2A0558F9272</gtr:id><gtr:title>Small molecule mediated bone regeneration using a degradable polymer membrane</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701855</gtr:grantReference><gtr:abstractText>Rising levels of obesity are directly leading to an explosion in the number of diabetic individuals. While there are many health implications as a result of this disease one that becomes of serious concern is the development of gum disease. Infected and bleeding gums are at the mild end of the effects ? more aggressive disease leads to the loss of the bone that holds the teeth. At this point it is necessary to undertake surgery in order to try and restore the height of the jaw bone. This grant outlines a new approach to such surgery using an advanced material that can stimulate new bone to grow (through the delivery of a chemical analogue of a protein known as hedgehog) but has the mechanical strength needed to resist the forces in the mouth, as well as being degradable. This material will also have applications in other areas that require the delivery of a drug from a stiff material, including repair of traumatic injuries to the legs and arms that currently require amputation.</gtr:abstractText><gtr:technicalSummary>The objective is to formulate a degradable polymer membrane capable of small molecule release within a guided bone regeneration context. The hedgehog pathway is critical for bone formation during embryogenesis and we have shown that exogenous stimulation of the pathway within a bone environment can promote dramatic new bone formation. The pathway is also amenable to small molecule stimulation via readily available agents; we have used purmorphamine. Guided bone regeneration protocols rely on the exclusion of wound contaminating tissues, enabling bone repair to proceed within a protected space: the procedure is used in craniofacial augmentation and in modified form has potential for orthopaedic applications. We propose to develop a novel form of degradable polymer membrane that will directionally release the purmorphamine hedgehog agonist into the protected space, promoting bone formation, but will degrade removing the need for a second surgical intervention. The membrane will combine four novel features: 1) stimulation of the hedgehog pathway, 2) small molecule release, 3) a multi-layered directional release structure, 4) post-placement stiffening of the polymer via incorporation of reactive fillers. This proposal relates to the formulation of the membrane in terms of polymer character and material structure to provide the desired release kinetics, degradation rate and material properties. Methodology: fabrication will be based on short triblock monomers ? poly(propylene glycol-co-lactide) dimethacrylate (PPGLADMA). Purmorphamine will be dissolved within the monomers, spread into a thin layer and light cured (methacrylate cross-linking). Purmorphamine is active in the 2 microMolar range and hence incorporation of a significant drug reservoir will be possible suitable for long-term sustained release. Drug release will be determined using a sensitive bioassay (hedgehog-responsive Light II cells). Successive covalently bonded layers will then be laid down to inhibit diffusion out of the placement site and also to confer greater mechanical properties. The use of a layer with reactive filler (monocalcium phosphate and beta-tricalcium phosphate) will confer water-dependent increase in storage modulus (stiffness) ? after placement the membrane will become rigid (a 40-fold increase in stiffness occurs over 24 hours). As the layers have distinct functions, material development can proceed in parallel, rather than sequentially; the final product will then be tested versus a standard resorbable membrane in vivo. The technology that we describe has immediate applications in alveolar ridge augmentation but contains several novel aspects ? not least the development of a mechanically competent drug-delivery mechanism that is light curable and hence extremely versatile.</gtr:technicalSummary><gtr:fund><gtr:end>2009-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>99285</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ozics</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Development of novel bone cements</gtr:description><gtr:id>EB9669C5-CA69-4611-B54C-98C94D70E8E7</gtr:id><gtr:impact>Funding obtained to develop a new bone cement. Ozics funded a PhD student that helped in the characterisation of their new product Comp06. These studies involved assesment of setting chemistry, mechanical properties and in vivo work. 
 - see 
http://www.prlog.org/11712867-swiss-ozics-group-announces-ce-mark-for-the-compo6-tm-bone-reinforcement-composite.html</gtr:impact><gtr:outcomeId>2C5E5E5C3A3-1</gtr:outcomeId><gtr:partnerContribution>patent costs and suport of a studentship</gtr:partnerContribution><gtr:piContribution>We advised Ozics on how to make and then analysed a new injectable cement produced by a commercial manufacturer (Sci Pharm) for vertebroplasty</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Ozics group</gtr:description><gtr:end>2012-10-02</gtr:end><gtr:fundingOrg>Ozics</gtr:fundingOrg><gtr:fundingRef>Ozics</gtr:fundingRef><gtr:id>25B6069C-BB1F-4150-A0E8-BF4A3AD62E07</gtr:id><gtr:outcomeId>5ed3b0145ed3b028</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>439985</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/I022341/1</gtr:fundingRef><gtr:id>BBC0E9F5-E41E-4D21-9BA4-334A8EA71BAB</gtr:id><gtr:outcomeId>5ed737525ed73766</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>535000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Healthcare partnership</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>ref EP/ I022341/1</gtr:fundingRef><gtr:id>F7C67601-1C8D-4C1F-A6E4-410117393117</gtr:id><gtr:outcomeId>gRFBitXyaVx</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>261751</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/F019866/1</gtr:fundingRef><gtr:id>869080A1-02C2-48FC-A3E7-65B055CD9A87</gtr:id><gtr:outcomeId>5ed527465ed5275a</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>980000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>i4i</gtr:description><gtr:end>2018-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>II-LA-0214-20002</gtr:fundingRef><gtr:id>6489110F-284E-422E-92FF-5CC4354B07F5</gtr:id><gtr:outcomeId>544e20993f8b03.38689034</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>This patent describes various degradable and non degradable cements for tooth and bone repair that contain reactive calcium phosphate fillers</gtr:description><gtr:grantRef>G0701855</gtr:grantRef><gtr:id>E231EA59-CD45-4BF2-BCCF-AEFAF5FDF759</gtr:id><gtr:impact>We currently have funding to optimise, manufacture and CE mark a product over the next three years</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>tJXW4mT33iq</gtr:outcomeId><gtr:patentId>WO2008037991</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Formulations and Composites with reactive fillers</gtr:title><gtr:yearProtectionGranted>2008</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>Guided tissue regeneration membranes are used to hold back soft tissue and allow bone to regenerate.</gtr:description><gtr:id>62F80230-FE98-4607-A5B1-2541B5AB1D8E</gtr:id><gtr:impact>The new materials in addition to the above function provide calcium and phosphate release as well as a small drug that can promote bone repair</gtr:impact><gtr:outcomeId>9E9FA5F8EF5</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>On hold</gtr:status><gtr:title>periodontal membrane</gtr:title><gtr:type>Therapeutic Intervention - Cellular and gene therapies</gtr:type><gtr:yearDevCompleted>2009</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>A new bone cement for vertebroplasty (fixation of osteoporotic vertebra)</gtr:description><gtr:id>CECF0BB2-80F8-40E9-9EA3-ECEDD8D7D226</gtr:id><gtr:impact>This product is being sold by a new company</gtr:impact><gtr:outcomeId>Lz3fU6C2bYx</gtr:outcomeId><gtr:stage>Market authorisation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Bone cement</gtr:title><gtr:type>Therapeutic Intervention - Medical Devices</gtr:type><gtr:url>http://www.ozics.com</gtr:url><gtr:yearDevCompleted>2011</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>7F276997-25B2-4F07-86CA-A385A628AD26</gtr:id><gtr:title>Cell attachment and response to photocured, degradable bone adhesives containing tricalcium phosphate and purmorphamine.</gtr:title><gtr:parentPublicationTitle>Acta biomaterialia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94237ac61513ad8bbaf49f9e76d61806"><gtr:id>94237ac61513ad8bbaf49f9e76d61806</gtr:id><gtr:otherNames>Gellynck K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1742-7061</gtr:issn><gtr:outcomeId>doi_53cfe2fe2107f9e8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DEC3CAC-2428-447A-9E75-10009F0014AB</gtr:id><gtr:title>Viscoelastic and biological performance of low-modulus, reactive calcium phosphate-filled, degradable, polymeric bone adhesives.</gtr:title><gtr:parentPublicationTitle>Acta biomaterialia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dae15e139378ae8a150276822e06dcfc"><gtr:id>dae15e139378ae8a150276822e06dcfc</gtr:id><gtr:otherNames>Abou Neel EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1742-7061</gtr:issn><gtr:outcomeId>doi_53cfe2fe216dde71</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26D237E3-1EE8-4553-9C3B-3C79C8F7433B</gtr:id><gtr:title>Chemical, modulus and cell attachment studies of reactive calcium phosphate filler-containing fast photo-curing, surface-degrading, polymeric bone adhesives.</gtr:title><gtr:parentPublicationTitle>Acta biomaterialia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dae15e139378ae8a150276822e06dcfc"><gtr:id>dae15e139378ae8a150276822e06dcfc</gtr:id><gtr:otherNames>Abou Neel EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1742-7061</gtr:issn><gtr:outcomeId>doi_53cfe2fe20c4994a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BFF6FC9-2FFE-4A43-BFAC-3DF9F444F75A</gtr:id><gtr:title>Reactive calcium-phosphate-containing poly(ester-co-ether) methacrylate bone adhesives: chemical, mechanical and biological considerations.</gtr:title><gtr:parentPublicationTitle>Acta biomaterialia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f76706732cc4158a7609b4aa9382a37e"><gtr:id>f76706732cc4158a7609b4aa9382a37e</gtr:id><gtr:otherNames>Zhao X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1742-7061</gtr:issn><gtr:outcomeId>doi_53cfe2fe20a70acd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>994B9F92-4167-4A33-92C1-3B09B1319000</gtr:id><gtr:title>Chemical characterization of a degradable polymeric bone adhesive containing hydrolysable fillers and interpretation of anomalous mechanical properties.</gtr:title><gtr:parentPublicationTitle>Acta biomaterialia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3457936797ccbfd7d9ba22f0029cdf0e"><gtr:id>3457936797ccbfd7d9ba22f0029cdf0e</gtr:id><gtr:otherNames>Young AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1742-7061</gtr:issn><gtr:outcomeId>doi_53cfe2fe202d5ff9</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701855</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>